Ethical considerations in cluster headache research
- 34 Downloads
Cluster headache is the most painful of the primary headache disorders and elucidating pathophysiology and treatment for this disorder is crucial. There is justification for studying attacks untreated, and even for precipitating these attacks. Placebo-controlled studies should only be undertaken for regulatory purposes; otherwise, active control should be used.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Headache Classification Committee of the International Headache Society [no authors listed]. Cephalalgia 1988, 8(suppl 7):1–96.Google Scholar
- 4.Mathew NT: Cluster headache: clinical features and pathophysiology. Semin Headache Manage 1996, 1:1–4.Google Scholar
- 10.van VlietJA, Bahra A, Martin V, et al.: Intranasal sumatriptan is effective in the treatment of acute cluster headache: a double-blind placebo-controlled crossover study [abstract]. Cephalalgia 2001, 21:270–271.Google Scholar
- 13.Phillips SB, Bernstein JE, and the Intranasal Civamide Study Group: Intranasal civamide: a novel neuropeptide active agent in development for the treatment of migraine and cluster headache [abstract]. Cephalalgia 2000, 20:333. Examines non-triptan nasal sprays for cluster headache.Google Scholar
- 14.Maxwell RE: Surgical control of chronic migrainous neuralgia by trigeminal gangliorhizolysis. J Neurol Surg 1982, 57:459–466.Google Scholar
- 18.Leone M, Franzini A, D’Amico D, et al.: Stereotactic electrode implant in inferior posterior hypothalamic gray matter to relieve intractable chronic cluster headache: the first reported case [abstract]. Neurology 2001, 56(suppl 3):A218; also in Cephalalgia 2001, 21:503. An exciting new abstract describing the one case in which the hypothalamic gray was instrumented to stop cluster headache.Google Scholar